Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice (Q37256499)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 August 2008

edit

Language	Label	Description	Also known as
English	Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice	scientific article published on 30 August 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

main subject

anticoagulation

1 reference

based on heuristic

inferred from title

anticoagulant

1 reference

based on heuristic

inferred from title

author name string

Laurent Becquemont

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

publication date

30 August 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

published in

European Journal of Clinical Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

volume

64

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

page(s)

953-960

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

cites work

Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00228-008-0542-2

retrieved

21 January 2018

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug hypersensitive syndrome caused by fluindione

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The largest prospective warfarin-treated cohort supports genetic forecasting

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of genetic and nongenetic factors in warfarin dosing algorithms

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C>T in a Chinese and a Caucasian population

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of bleeding risk using genetic markers in patients taking phenprocoumon

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic determinants of response to warfarin during initial anticoagulation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acenocoumarol stabilization is delayed in CYP2C93 carriers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: in-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic and environmental risk factors for oral anticoagulant overdose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered pharmacokinetics of R- and S-acenocoumarol in a subject heterozygous for CYP2C9*3.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acenocoumarol pharmacokinetics in relation to cytochrome P450 2C9 genotype

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP4F2 genetic variant alters required warfarin dose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Worldwide management of oral anticoagulant therapy: the ISAM study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetics of acenocoumarol pharmacodynamics.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of warfarin dose with genes involved in its action and metabolism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the gene for vitamin K epoxide reductase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18758764

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00228-008-0542-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

PubMed publication ID

18758764

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18758764

retrieved

19 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37256499&oldid=2200092692"